Studies on the interaction of placental anticoagulant protein I, β2glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays
- 31 August 1996
- journal article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 128 (2) , 194-201
- https://doi.org/10.1016/s0022-2143(96)90011-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of prothrombin activation by antiphospholipid antibodies and β2‐glycoprotein 1British Journal of Haematology, 1994
- Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?British Journal of Haematology, 1993
- β2‐glycoprotein 1 (β2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodiesBritish Journal of Haematology, 1992
- Lupus‐like anticoagulant properties of murine monoclonal antibodies to β2‐glycoprotein IBritish Journal of Haematology, 1992
- What is the "true" antigen for antiphospholipid antibodies?The Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Inhibition of phospholipid and platelet‐dependent prothrombinase activity in the plasma of patients with lupus anticoagulantsBritish Journal of Haematology, 1989
- SYNDROME OF THE BLACK SWANRheumatology, 1987
- Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-IBiochimica et Biophysica Acta (BBA) - General Subjects, 1986